Evidence map›Paper›PMID 36484910›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2023

Dark-purple rice extract modulates gut microbiota composition in acetic acid- and indomethacin-induced inflammatory bowel disease in rats.

Kornsuda Thipart, Lucsame Gruneck, Kutcharin Phunikhom, Thomas J Sharpton, Jintana Sattayasai, Siam Popluechai

Abstract read
PubMed Publisher
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. International journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Frontiers in veterinary science · 2024
    Article
  12. Polysaccharides derived from golden mushroom (Frontiers in pharmacology · 2024
    Article
  13. Review
  14. International journal of molecular sciences · 2023
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kornsuda Thipart *Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Lucsame Gruneck *Gut Microbiome Research Group, Mae Fah Luang University, Chiang Rai, Mueang, Thailand.
Kutcharin PhunikhomDepartment of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Thomas J SharptonDepartment of Microbiology, Oregon State University, Corvallis, OR, 97331, USA.
Jintana SattayasaiDepartment of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Siam PopluechaiGut Microbiome Research Group, Mae Fah Luang University, Chiang Rai, Mueang, Thailand. siam@mfu.ac.th.
Khon Kaen University · THMae Fah Luang University · THOregon State University · USPrince of Songkla University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis (UC) and Crohn's disease (CD) are two major forms of inflammatory bowel disease (IBD). The disease has been linked with gut microbiota dysbiosis in which the balance of commensal communities is disrupted. Accumulating evidence demonstrates that treatment with biologically active compounds can modulate gut microbiota composition in animal models. Our previous work has also shown the beneficial effect of Luem Pua (LP) rice extract, which is rich in anthocyanins, on inflammation. However, its effect on gut microbiota is yet to be explored. In this study, we profiled fecal microbiota of acetic acid (AA)-induced UC and indomethacin (ID)-induced CD rat models with and without pretreatment with LP rice extract by 16S rRNA gene sequencing. The results showed that gut microbiota communities of rats were altered by both AA-induced UC and ID-induced CD. The relative abundances of beneficial bacteria, especially the Lachnospiraceae NK4A136 group and Lactobacillus, were decreased in the AA-induced UC model, while some opportunistic pathogens (Bacteroides, Escherichia/Shigella, Fusobacterium, and Veillonella) were raised by ID-induced CD. Interestingly, pretreatment with LP rice extract before AA-inducing UC in rats increased the proportion of the butyrate-producing bacteria (Lachnospiraceae NK4A136 group). The abundances of these beneficial bacteria and other SCFA-producing bacteria were unaffected by the indomethacin treatment with LP. Overall, our study revealed different impacts of AA-induced UC and ID-induced CD on changes in community composition and hinted at how LP may protect against UC by modifying the gut microbiota.

Indexed as

Colitis, UlcerativeCrohn DiseaseGastrointestinal MicrobiomeInflammatory Bowel DiseasesOryzaAcetic AcidAnimalsAnthocyaninsBacteriaIndomethacinRatsRNA, Ribosomal, 16SAcetic AcidAnthocyaninsIndomethacinRNA, Ribosomal, 16SGut microbiotaInflammatory bowel diseaseLP rice extractRats

Identifiers

PMID36484910
OpenAlexW4310950447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.